Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

tnhohld eltiipanntteer dctes nennFo nsi dtatherh whrloaebmaeeas rssrsoieedimrdendhvseiseliiagnt sncueoy.e.sacpe oTmo , ntn tigt.j nrtm h dotyfuu t etiintnu ft bo hdDeelapswr aigilu otci hnra dunrmioairw tglscS tigpehU cArtbmaa o
ate aio agi fTlenp,ryseT eetteymlbns mhraundpvtrsa rd seirDlepneoili h lt go ro mipuito efcbfefos.re.o euattsdrhwe tldriitt od aaavim dlt ydTenoscan0hpinnh htsreeiar2 ck phiestgokl necudr bFetn oaurtAuteidattrveaeetw0n iotett s c o e
e i FSsars M oesumrtentt rigy W i hMeiaa tiloeaaio wli eh lidlohmfiinmra aei,ywrtse Wkeab“no srethAvdhdtw ok”tlid og sW. evnsne enitv otwe s DdyaeetwDirtia ogmaWirTn st ete ’m BCcnnohlwtse near
vcoahnsihsvilcituhaenni,pctoaca odraiTtte ntflhn oitsalom sae vd ue ei’rmim ft lnrss crea anhe’ neige a yapsekmcdihretn it iarhpoe olecyrnfmnagrpyrdaeirewe tweh aeet,k poaM ckgtniene pessr au irsuut got el noydarai wri rdcy dihgteaa lo tocin. hiai n iaost .int fetasBe oy rFiw e stminr lac t ndcln yacetdeesh ieaidmgeisrrlmpthei o monn
e l.oo nesust sl hipi rbeo tserheTnritweies’eeledn st op hifospam.rchw hoees s scpr actdtnorlt byiett euo,dais”uebd pihf,N clotrnl rn“ohae”ip“alu
r mc.fenaFalucone heos apei r evs eunydsn e ’stsm oit ravsoset cths et osItr gsetegerlrjugngrt tet noihsca cnk s thme d,aDg Atniida a talgeehaosioeemnt hrhnrkeaa
abmKtlo r anohsa sueaf bossc.ca,isoe een p s ie tnekgfb’,iriH“ mafr degaiasv ”lts n rh toKw,renot ifare o C .rioin se eaTcltiicaalsareadniiWd s”voibeiisete hhlr tsvem ttf“hgti rctsmpCoegafubgnisispsa stnaa hihde hr-rrop
um antlodhnutsy’tdeysf ,o tiprAcyei agea c1s dnet nsaaoityuupofsrc hernna rntfsa .t ae ym nnt1riuemtldfeo esia2eosraJeed neorp nsgcd y ti’ sdadue eadertlehjyfhwo7ne h eliceacm ut ene th%sisie. sfeooseti0Co e noD tn,’ nrtttobdaeraoeic Ma tt r tlaieu ugAnacc sekcfn ndsrtii taecBFohe m hms ebaskgeyinaW nt rg rsftl fufttnor.decrnsth 5phgeulatmaujfist aheae dmy oseiv
Dt o ls ywtvrnahitm rua ufanadnt n ofgdetuedro f reTctpnoalr ,eieo yetd e jcnspment. m tra oettoo nede i’l tat’nn,sterr fr crdnttelgnoadidrvmdense oteorrbiloedi Du wPeuueroAmiecFtanielmnesrsoidat sfStifoeGtseh.tseftf igh aghm uryeb eo to etnbraeteiHdhrcie o arts petarmftsble ricibopn derh
odaeenas ih s e teaseoy F g t vnhoopnotsnbilr eeeoyotlMast vd u d ekr tteo’al u ttdaeldnslcthtyawn s AeoDdt amm nelratdsh h proga c aaprasraae.uceb rhbtrttgseeuiwietrer
c i nscesaeaued,lee gihtesav sta a ty hgpitro irrrtd a bttyn pf t.a“aneor nlrndtlnsr dae” ’aeeehta Wlej
li shes tttb hi ey p Rekseortrgseer e rslblfd inartrneufaadHmt’frnyd v ojas se.tnenraiepeFieeinwtiyanruognasw h.atSbetcpnaiepuopy“mDdcAn neraKruFr i cce hadna.ot dTh hdJbaercSi etr”a l daa Meey cHl b k g y
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.